← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2019Last known activity
Mar 9, 2021
Acquired by Pharmacosmos on Nov 13, 2021
Timeline
2010s
- Jun 1, 2016
Abfero Pharmaceuticals, Inc— Founded
2020s
- Nov 13, 2021
Pharmacosmos— Acquired By
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04741542CollaboratorPhase 1Mar 9, 2021
- NCT03801889Lead sponsorPhase 2May 31, 2019
Details
- Founded
- Lexington, MA, US Jun 1, 2016
- Last known activity
- Mar 9, 2021